AVNphotolab / iStockphoto.com
A Brazilian federal judge has granted a preliminary injunction against a patent for US-based Gilead’s Sovaldi (sofosbuvir) drug, used to treat hepatitis C, following a complaint by a presidential candidate.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
INPI, patent, preliminary injunction, Gilead, hepatitis C, Gabriel Di Blasi, Di Blasi Parente & Associados, Marina Silva, Eduardo Jorge, Sovaldi